In July 2022, as per the IQVIA fact sheet, its Data Query System (DQS) used master data management in a highly robust searchable data repository that enables sponsors and CROs to find better-matched investigators and sites for their clinical trials and better support study planning.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-eclinical-solutions-market
Moreover, according to National Center for Science and Engineering Statistics (NCSES) data in 2020, the United States had spent USD 538 billion on research and development performance increase by 9.1% compared to spending in 2019.
Data Bridge Market Research analyses that the Global e-Clinical Solutions Market is expected to grow at a CAGR of 13.5% in the forecast period of 2023 to 2030 and is expected to reach USD 20,022.42 million by 2030. Electronic data capture and clinical data management systems are projected to propel the growth of the market as they are widely used in e-clinical solutions for collecting clinical trial data and analyzing medical data electronically.
Key Findings of the Study
The Growing Usage of e-Clinical Solutions in Clinical Trials
The clinical trial is the investigation procedure used to study drug development to assess the safety and efficacy of the molecule. The clinical trial is an extensive and complicated process that has raised the demand for an innovative and automated electronic solution to simplify and reduce clinical trial durations. Researchers and manufacturers developed automated electronic methods to provide assessment in clinical trial management systems.
The e-clinical solutions comprise Electronic Health Records, Electronic Consent Forms, Integrating e-Technologies, Electronic Data Capture, and Clinical Data Management Systems. The e-clinical solutions are helping researchers in end-to-end clinical research processes by providing solutions, through proper management of lengthy clinical research processes. It helps clinical research organizations with regulatory document management, team collaboration and management of supply chains, site performance management, and reporting, which is increasing demand for e-Clinical solutions in the market.
The e-clinical solutions have helped doctors and researchers to reduce the clinical trial cost, and duration, and to collect data. Thus, to reduce the chance of data loss and increase the number of clinical trials, which is increasing the usage of e-clinical solutions in clinical trials.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in Million, and Pricing in USD
|
|
Segments Covered
|
By Product (Electronic Data Capture and Clinical Trial Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Care Coordination Medical Records (CCMR), Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premises) Solutions, and Cloud-Based (SAAS) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Small & Medium and Large), User Device (Desktop, Tablet, Handheld PDA Device, Smart Phone, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutes)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Israel, Egypt, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Oracle (U.S.), Signant Health (U.S.), MaxisIT (U.S.), Paraxel International Corporation (U.S.), Dassault Systemes (France), Clario (U.S.), Mednet (U.S.), OpenClinica, LLC (U.S.), 4G Clinical (U.S.), Veeva Systems (U.S.), Saama Technologies, LLC (U.S.), Anju (U.S.), Castor, Medrio, Inc. (U.S.), ArisGlobal (U.S.), Merative (U.S.), Advarra (U.S.), eClinical Solutions, LLC (U.S.), Y-Prime LLC (U.S.), RealTime Software Solutions LLC (U.S.), Datatrak Int. (U.S.), IQVIA Inc. (U.S.), Research Manager (Netherlands), and Quretec (Estonia) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The e-clinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, organization size, user device, and end user.
- On the basis of product, the global e-clinical solutions market is segmented into electronic data capture and clinical trial data management systems, clinical trial management systems, clinical analytics platforms, care coordination medical records (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions and others
In 2022, the electronic data capture and clinical trial data management systems segment of the product segment is anticipated to dominate the global e-clinical solutions market
In 2022, the electronic data capture and clinical trial data management systems segment of this market will dominate the global e-clinical solutions market due to growing awareness pertaining to the advantages of EDC services over paper-based clinical information management. The electronic data capture and clinical trial data management systems segment is expected to reach the highest CAGR of 17.3% in the forecast period from 2023-2030.
- On the basis of delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions and cloud-based (SAAS) solutions. In 2023, the web-hosted (on-demand) solutions segment is expected to dominate the global e-clinical solutions market with 39.72% market share due to the advancements and innovation in the approaches of e-clinical solutions
- On the basis of clinical trial phase, the market is segmented into phase I, phase II, phase III, and phase IV. In 2023, the phase III segment is expected to dominate the global e-Clinical solutions market with 38.28% market share due to rising investments by the government and pharmaceutical companies towards clinical trials and drug development
- On the basis of organization size, the market is segmented into small & medium, and large. In 2023, the medium and small segment is expected to dominate the global e-Clinical solutions market with 62.61% market share due to the rising strategic initiatives by the various market players
- On the basis of user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others. In 2023, the desktop segment is expected to dominate the global e-Clinical solutions market with 49.57% market share due to the increasing usage of electronic gadgets among the population.
- On the basis of end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes. In 2023, the contract research organizations segment is expected to dominate the global e-Clinical solutions market with 40.32% market share due to a rise in patients with various disorders and rising research activities
Major Players
Data Bridge Market Research recognizes the following companies as the major e-Clinical solutions market players in the global e-Clinical solutions market Oracle (U.S.), Signant Health (U.S.), MaxisIT (U.S.), Paraxel International Corporation (U.S.), Dassault Systemes (France), Clario (U.S.), Mednet (U.S.), OpenClinica, LLC (U.S.), 4G Clinical (U.S.), Veeva Systems (U.S.), Saama Technologies, LLC (U.S.), Anju (U.S.), Castor, Medrio, Inc. (U.S.), ArisGlobal (U.S.), Merative (U.S.), Advarra (U.S.), eClinical Solutions, LLC (U.S.), Y-Prime LLC (U.S.), RealTime Software Solutions LLC (U.S.), Datatrak Int. (U.S.), IQVIA Inc. (U.S.), Research Manager (Netherlands), and Quretec (Estonia) among others.
Market Development
- In April 2023, Oracle as a leading supplier of operational and clinical technology for hospitals and healthcare systems globally, Oracle, Deloitte today announced the extension of its operating system for the healthcare industry to include implementing, operating, and advisory services for Oracle. Deloitte's growing portfolio of healthcare technology products, Deloitte Health—Oracle Accelerated, is created to keep up with the industry's transformation into a vast ecosystem and platform driven by patients rather than hospitals, providers, or insurance companies. Deloitte, a long-standing Oracle PartnerNetwork (OPN) member, is collaborating with Oracle Health to provide clients with a healthcare delivery system that is prepared for the future
- In April 2023, Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights, this will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
- In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering
- In July 2022, as per the IQVIA fact sheet, its Data Query System (DQS) used master data management in a highly robust, searchable data repository that enables sponsors and CROs to find better-matched investigators and sites for their clinical trials and better support study planning
- In February 2022, Advarra, the market leader in regulatory review solutions, research quality and compliance consulting services, and clinical research technology solutions announced the launch of their new Clinical Research Conduct Training aimed at streamlining site activation and reducing the training burden on sites
- In December 2021, Advarra has launched next generation cloud platform for clinical research which can improve the delivery of applications to automate, streamline, connect, and expedite processes across the clinical trial lifecycle
Regional Analysis
Geographically, the countries covered in the advanced wound care market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Israel, Egypt, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global e-clinical solutions market during the forecast period 2023 - 2030
In 2022, North America dominated the global e-clinical solutions market owing to the higher level of investments by U.S. manufacturers and increasing adoption of e-clinical solutions. North America will continue to dominate the e-Clinical solutions market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and the launch of new e-clinical solutions products in this region. Additionally, an increase in the number of clinical studies for drug development and discovery, and this is anticipated to propel the demand for EDC systems in this region.
North America is estimated to be the fastest growing region in the e-clinical solutions market in the forecast period from 2023 - 2030
North America is expected to grow during the forecast period due to the rapid development of medical facilities in emerging economies in this region. In addition to this, rising levels of healthcare expenditure and increasing per-capita income are expected to propel the market's growth rate in this region.
For more detailed information about the e-clinical solutions market report, click here - https://www.databridgemarketresearch.com/reports/global-eclinical-solutions-market
